19-Apr-2024
CVS favors Humira copycats hurting AbbVie’s market share: Evercore
Seeking Alpha News (Wed, 17-Apr 9:26 AM ET)
Freeport-McMoRan, AppLovin And A Major Healthcare Stock On CNBC's 'Final Trades'
Benzinga (Wed, 17-Apr 9:06 AM ET)
Nasdaq, S&P, Dow end mixed after hawkish Powell further clouds rate cut expectations
Seeking Alpha News (Tue, 16-Apr 4:11 PM ET)
UnitedHealth sends beaten-down peers higher after Q1 results
Seeking Alpha News (Tue, 16-Apr 2:06 PM ET)
UnitedHealth stock jumps as profit tops estimates
Seeking Alpha News (Tue, 16-Apr 7:06 AM ET)
Wells Fargo Sticks to Its Hold Rating for CVS Health (CVS)
TipRanks (Mon, 15-Apr 6:06 AM ET)
AbbVie Stock (NYSE:ABBV): Humira Leads Market with 96% Share
TipRanks (Mon, 15-Apr 2:30 AM ET)
Aetna Better Health of Michigan recommended for CHCP contract
PRNewswire (Tue, 9-Apr 12:00 PM ET)
CVS Health expands pharmacy tuition assistance and scholarship programs
PRNewswire (Wed, 3-Apr 8:00 AM ET)
CVS Bearish Calendar Put Spread is Inexpensive at 49 Cents
Market Chameleon (Tue, 2-Apr 12:48 PM ET)
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the U.S. CVS is also the largest pharmacy benefit manager (acquired through Caremark), processing over 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 26 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all its existing business lines.
CVS Health trades on the NYSE stock market under the symbol CVS.
As of April 19, 2024, CVS stock price climbed to $69.75 with 7,400,942 million shares trading.
CVS has a beta of 0.62, meaning it tends to be less sensitive to market movements. CVS has a correlation of 0.07 to the broad based SPY ETF.
CVS has a market cap of $87.78 billion. This is considered a Large Cap stock.
Last quarter CVS Health reported $94 billion in Revenue and $2.12 earnings per share. This beat revenue expectation by $3 billion and exceeded earnings estimates by $.13.
In the last 3 years, CVS stock traded as high as $111.25 and as low as $64.41.
The top ETF exchange traded funds that CVS belongs to (by Net Assets): VTI, VOO, SPY, IVV, VTV.
CVS has underperformed the market in the last year with a price return of -5.1% while the SPY ETF gained +21.2%. CVS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -3.8% and -5.6%, respectively, while the SPY returned +4.3% and -3.5%, respectively.
CVS support price is $67.61 and resistance is $69.84 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CVS stock will trade within this expected range on the day.